Tiplaxtinin (PAI-039): Mechanism of Action

Tiplaxtinin (PAI-039) MOA：Targeting PAI-1/JAK-STAT Pathway for Oncology and Cancer Research

🎯 check Tiplaxtinin (PAI-039) product page

Tiplaxtinin (PAI-039) is a potent PAI-1 inhibitor. It affects Aβ signaling by reducing Aβ40 binding, promoting Aβ40 endocytosis.

Primary Applications and Mechanism of Action

Jump to: